The Stavros Niarchos Foundation Global Pediatric Cancer Program

Ira J. Dunkel, MD, and Gurcharanjeet Kaur, MD, FAAP
Ira J. Dunkel, MD, and Gurcharanjeet Kaur, MD, FAAP

Optimizing Pediatric Cancer Care Around the World

About 400,000 children are diagnosed with cancer each year around the world, and more than 80% of them live in low- and middle-income countries. At MSK Kids, we believe it’s not enough to have excellent cancer care in some places and not others; high-quality pediatric cancer care must be available everywhere.

Toward that goal, MSK Kids is forging collaborations with institutions across the globe through the Stavros Niarchos Foundation (SNF) Global Pediatric Cancer Program to optimize outcomes for children with cancer. Established with a grant from SNF as part of its Global Health Initiative (GHI), the effort enables MSK Kids to bring its deep expertise in pediatric oncology to young patients around the world through new collaborations and peer exchanges with hospitals and other healthcare providers.

Damon Reed, Pediatric Hematologist-Oncologist reviewing an MRI of osteosarcoma with Carol Morris, MD, MS, Orthopaedic Surgeon.
Damon Reed, Pediatric Hematologist-Oncologist reviewing an MRI of osteosarcoma with Carol Morris, MD, MS, Orthopaedic Surgeon.

Our Vision

We envision a world where every child with cancer, no matter where they live, has access to timely and effective expert care.

The SNF Global Pediatric Cancer Program aims to:

  • Improve access to expert diagnostic and treatment planning for pediatric patients across the globe.
  • Establish a network of partner hospitals to serve as regional hubs to amplify reach to low- and middle-income countries.
  • Facilitate global learning and collaboration in pediatric oncology through innovative education and training programs.
  • Address disparities in childhood cancer by sharing MSK Kids’ clinical expertise and leadership in cancer care and health equity — directly and through international partner institutions.

 

 

Enhancing Patient Care

Through the SNF Global Pediatric Cancer Program, MSK Kids clinical care experts collaborate with global partners to enhance diagnostic precision, offer expert clinical insights, and expand access to specialized testing and program development resources.

Expanding Knowledge

The SNF Global Pediatric Cancer Program connects healthcare professionals worldwide with the latest pediatric oncology knowledge, empowering them to apply best practices within their own hospitals and healthcare systems.

Advancing Pediatric Cancer Research

Research is an integral part of the mission of the SNF Global Pediatric Cancer Program, with the goal of expanding global research initiatives, broadening patient access to clinical trials, and strengthening research capabilities at international institutions.

 

Our Team

MSK pediatric oncologist Maria Cancio
Associate Attending Pediatrician
Memorial Sloan Kettering pediatric oncologist Ira Dunkel
Attending Pediatrician
Memorial Sloan Kettering pediatric oncologist Andrew Kung
Chair, Department of Pediatrics; Lila Acheson Wallace Chair for Pediatric Research
Memorial Sloan Kettering pediatric oncologist Shakeel Modak
Chief, Neuroblastoma Service
Damon Reed
Division Head, Pediatric Solid Tumors; Chief, Pediatric Sarcoma Service
Memorial Sloan Kettering pediatric hematologic oncologist Neerav Shukla
Chief, Pediatric Translational Medicine Service (PTMS); Bristol-Myers Squibb/James D. Robinson III Junior Faculty Chair
Memorial Sloan Kettering pediatric hematologic oncologist Tanya Trippett
Associate Attending Pediatrician
Connect With Us

MSK Kids is excited to collaborate with institutions around the world to bring our expert clinical, education, and research expertise in pediatric cancer across the globe.

To learn more about the SNF Global Pediatric Cancer Program or to inquire about partnerships, please contact Penny Tsougas.

News and Events

Memorial Sloan Kettering Cancer Center Launches SNF Global Pediatric Cancer Program To Expand Access to Renowned Pediatric Cancer Care Worldwide
The program, established through a $25 million grant from the Stavros Niarchos Foundation (SNF) as part of its Global Health Initiative, aims to improve outcomes for pediatric cancer patients through international healthcare collaborations.